T T L Wong1, J T Daniels, J G Crowston, P T Khaw. 1. Department of Pathology, Institute of Ophthalmology, 11-43 Bath Street, London EC1V 9EL, UK. tina.wong@ucl.ac.uk
Abstract
PURPOSE: The development of posterior capsule contraction following cataract surgery is caused by the activity of residual lens epithelial cells. Matrix metalloproteinases (MMPs) are a group of proteolytic enzymes, which are essential for cell migration and cell mediated contraction following wound healing. The authors investigated whether inhibiting MMP activity can reduce lens epithelial cell migration and as a result, lead to a reduction in cell mediated capsule contraction. METHODS: Human donor lens capsules were cultured and treated with a broad spectrum MMP inhibitor, Ilomastat (GM6001). MMP-2 and MMP-9 production were determined by ELISA. Cell migration onto the posterior capsule and capsule contraction were digitally measured. RESULTS: MMP inhibition significantly reduced lens epithelial cell migration onto the posterior capsule (p<0.05), and a reduction in capsule contraction was observed (p<0.05). CONCLUSIONS: Ilomastat significantly reduced lens epithelial cell migration onto the posterior capsule surface and inhibited capsule contraction. MMP inhibition may have a role in the therapeutic treatment of posterior capsule opacification.
PURPOSE: The development of posterior capsule contraction following cataract surgery is caused by the activity of residual lens epithelial cells. Matrix metalloproteinases (MMPs) are a group of proteolytic enzymes, which are essential for cell migration and cell mediated contraction following wound healing. The authors investigated whether inhibiting MMP activity can reduce lens epithelial cell migration and as a result, lead to a reduction in cell mediated capsule contraction. METHODS:Humandonor lens capsules were cultured and treated with a broad spectrum MMP inhibitor, Ilomastat (GM6001). MMP-2 and MMP-9 production were determined by ELISA. Cell migration onto the posterior capsule and capsule contraction were digitally measured. RESULTS: MMP inhibition significantly reduced lens epithelial cell migration onto the posterior capsule (p<0.05), and a reduction in capsule contraction was observed (p<0.05). CONCLUSIONS:Ilomastat significantly reduced lens epithelial cell migration onto the posterior capsule surface and inhibited capsule contraction. MMP inhibition may have a role in the therapeutic treatment of posterior capsule opacification.
Authors: Tina T L Wong; Charanjit Sethi; Julie T Daniels; G Astrid Limb; Gillian Murphy; Peng T Khaw Journal: Surv Ophthalmol Date: 2002 May-Jun Impact factor: 6.048
Authors: D J Apple; Q Peng; N Visessook; L Werner; S K Pandey; M Escobar-Gomez; J Ram; G U Auffarth Journal: Ophthalmology Date: 2001-03 Impact factor: 12.079
Authors: U Ozerdem; B Mach-Hofacre; L Cheng; S Chaidhawangul; K Keefe; C D McDermott; G Bergeron-Lynn; K Appelt; W R Freeman Journal: Curr Eye Res Date: 2000-06 Impact factor: 2.424
Authors: D J Apple; K D Solomon; M R Tetz; E I Assia; E Y Holland; U F Legler; J C Tsai; V E Castaneda; J P Hoggatt; A M Kostick Journal: Surv Ophthalmol Date: 1992 Sep-Oct Impact factor: 6.048
Authors: Gerhard J Weber; Sung E Choe; Kimberly A Dooley; Noëlle N Paffett-Lugassy; Yi Zhou; Leonard I Zon Journal: Blood Date: 2005-04-12 Impact factor: 22.113